3 reasons COVID-19 vaccines remain in short supply
Though the U.S. has invested billions of dollars in COVID-19 vaccine manufacturing and invoked the Defense Production Act to boost supplies needed to make the vaccines, there are still not enough doses to meet demand, Kaiser Health News reported Feb. 23.